BridgeBio(BBIO) GlobeNewswire News Room·2025-03-17 20:01Core Insights - BridgeBio Pharma, Inc. has appointed Thomas Trimarchi, Ph.D. as President and Chief Financial Officer, who will continue to oversee FP&A and accounting operations [1] - Brian Stephenson, Ph.D. is departing from the company for personal reasons but will remain as a consultant [2] - Dr. Stephenson expressed pride in his contributions to the company and its innovative financial model aimed at serving patients with genetic diseases [3] Company Overview - BridgeBio Pharma, Inc. is a biopharmaceutical company focused on discovering, creating, testing, and delivering transformative medicines for genetic diseases [4] - The company was founded in 2015 and has a pipeline that includes programs from early science to advanced clinical trials [4] - The team is dedicated to applying advances in genetic medicine to expedite patient care [4]